Reduction in platelet aggregation (in vitro) by diallyl sulphide in female participants with type 2 diabetes mellitus

Journal of Pharmacology and Toxicology

Volumn 6, Issue 4, 2011, Pages 381-390

  Abhaykumar, ^a   Nirmala, K ^a   Prasad, M P R ^a   Panpatil, Virendra V ^a   Prasanna Krishna, T ^a   Sesikeran, B ^a   Polasa, K ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Adenosinge diphosphae; Aspirin; Diallyl supphide; Platelet aggregation; Type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ALLYL SULFIDE; FIBRINOGEN; GLUCOSE; HEMOGLOBIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERTENSION; IN VITRO STUDY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE RICH PLASMA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79955943424     PISSN: 1816496X     EISSN: 2152100X     Source Type: Journal    
DOI: 10.3923/jpt.2011.381.390     Document Type: Article

References (37)

1. Al-Shahi, R. and C. Warlow, 2000. Editorials using patient-identifiable data for observational research and audit. Br. Med. J., 321: 1031-1032.
2. Avogaro, A., C. Giorda, M. Maggini, E. Mannucci and R. Raschetti et al., 2007. Incidence of coronary heart disease in type 2 diabetic men and women: Impact of micorvascular complications, treatment and geographic location. Diabetes Care, 30: 1241-1247.
3. Banerjee, S.K. and S.K. Maulik, 2002. Effect of garlic on cardiovascular disorders: A review. Nutr. J., 1: 4-4.
4. Bordia, A., 1978. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis, 30: 355-360.
5. Born, G.V.R. and M.J. Cross, 1963. Effect of adenosine diphosphate on the concentration of platelets in circulating blood. Nature, 197: 974-976.
6. Buse, J.B., H.N. Ginsberg, G.L. Bakris, N.C. Clark, F.S. Costa and N.J. Stone, 2007. Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American heart association and the American diabetic association. Circulation, 115: 114-126.
7. Fontana, P., A. Dupont, S. Grandrille, C. Bachelot-Loza, J.L. Reny, M. Hiach and P. Gaussem, 2003. Adenosine diphosphate?induced platelet aggregation is associated with P2Y12 gene sequence variation in healthy subjects. Circulation, 108: 989-995.
8. Fontana, P., S. Grandrille, V. Remones, A. Dupont, J.L. Reny, M. Aiach and P. Gaussem, 2006. Identification of functional polymorphisms of the thromboxane A2 recetpor gene in healthy volunteers. Thromb. Haemost., 96: 356-360.
9. Friedewald, W.T., R.I. Levy and D.S. Fredrickson, 1972. Friedewald formula: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of preparative ultracentrifugation. Clin. Chem., 18: 499-502.
10. George, J.N. and S.J. Shattil, 1991. The clinical importance of acquired abnormalities of platelet function. N. Engl. J. Med., 324: 1670-1672.
11. Gheye, S., A.V. Lakshmi, T.P. Krishna and K. Krishnaswamy, 1999. Fibrinogen and Homoysteine levels in coronary artery disease. Indian Heart J., 51: 499-502.
12. Hasani-Ranjbar, S., N. Nayebi, L. Moradi, A. Mehri, B. Larijani and M. Abdollahi, 2010. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia: A systematic review. Curr. Pharm. Des., 16: 2935-2947.
13. Hemingway, H., C. Langenberg, J. Damant, C. Frost, K. Pyorala and E. Barrett-Connor, 2008. Prevalence of angina in women versus men: A systematic review and meta-analysis of international variations across 31 countries. Circulation, 117: 1526-1536.
14. Jazani, N.H., S. Shahabi, A.A. Ali, S. Zarrin and N.A. Daie, 2007. In vitro antibacterial activity of garlic against burn isolated strains of Acinetobacter spp. J. Biol. Sci., 7: 819-822.
15. Lazarus, B.S., K. Bowen and M.L. Garg, 2004. Tomato juice and platelet aggregation in type 2 diabetes. J. Am. Med. Assoc., 292: 805-806.
16. Li, G., Z. Shi, H. Jia, J. Ju and X. Wang et al., 2000. A clinical investigation on garlicin injection for treatment of unstable angina pectoris and its actions on plasma endothelin and blood sugar levels. J. Tradit. Chin. Med., 20: 243-246.
17. Martha, T., K. Al-Qattan, M. Al-Houli, J.S. Divya, J. Al-Hassan, S. Al-Sawan and A. Muslim, 2010. Influence of garlic and ginger compared to aspirin on diabetic indicators in STZ-induced diabetic rats. FASEB J., 24: 335-345.
18. Matsuna, H., H. Tokuda, A. Ishisaki, Y. Zhou, Y. Kitajima and O. Kozawa, 2005. P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes. J. Clin. Endocrinol. Metab., 90: 920-927.
19. Matthew, S.B., T. Pierluigi and A.H. Robert, 2009. A new generation of antiplatelet agents. Curr. Opin. Cardiol., 24: 307-312.
20. Menys, V.C., D. Bhatnagar, M.I. Mackners and P.N. Dunington, 1995. Spontaneous platelet aggregation in whole blood is increased in non-insulin dependent diabetes mellitus and in female but not male patients with primary dyslipidemia. Atherosclerosis, 112: 115-122.
21. Nagini, S., 2008. Cancer chemoprevention by garlic and its organosulfor compounds-panacea or promise. Anticancer. Agents Med. Chem., 8: 313-321.
22. Nouri, M., M.H. Pipelzadeh and A. Badiei, 2008. A comparative study on the effectiveness of garlic with clofibrate in the treatment of hyperlipidemia. J. Medical Sci., 8: 85-89.
23. Paramo, J.A., O. Beloqui, C. Roncal, A. Benito and J. Orbe, 2004. Validation of plasma fibrinogen as a marker of carotid atherosclerosis in subjects of clinical cardiovascular disease. Haematologica, 89: 1226-1232.
24. Polasa, K. and K. Krishanswamy, 1997. Reduction in urinary mutagen excretion in rats fed garlic. Cancer Lett., 114: 185-186.
25. Rahman, K., 2007. Effects of garlic on platelet biochemistry and physiology. Mol. Nutr. Food Res., 51: 1335-1344.
26. Ratinoff, O.D. and C. Menzie, 1951. A new method for the determination of fibrinogen in small samples of plasma. J. Lab. Clin. Med., 37: 316-320.
27. Reinhart, K.M., R. Talati, C.M. White and C.I. Coleman, 2009. The impact of garlic on lipid parameters: A systematic review and meta-analysis. Nutr. Res. Rev., 22: 39-48.
28. Saeed, S.A., H. Rasheed, T.M. Ali, Y. Qazi and S. Kabraji et al., 2004. Mechanism of inhibitory action of cyclooxygenase-2 inhibitors in human platelets. J. Biol. Sci., 4: 515-520.
29. Shai, I., J.D. Spence, D. Schwarzfuchs, Y. Henkin and G. Parraga et al., 2010. Dietary intervention to reverse carotid atherosclerosis. Circulation, 121: 1200-1208.
30. Siegel, R.D., A. Cupples, E.J. Schaefer and P.W.F. Wilson, 1996. Lipoproteins, apolipoproteins and low density lipoproteins size among diabetics in the Framingham offspring study. Metabolism, 45: 1267-1272.
31. Stern, M.P., 1995. Diabetes and cardiovascular diseases. The common soil hypothesis. Diabetes, 44: 369-374.
32. Sukandar, E.Y., H. Permana, I.K. Adnyana, J.I. Sigit, R.A. Ilyas, P. Hasimun and D. Mardiyah, 2010. Clinical study of turmeric (Curcuma longa L.) and garlic (Allium sativum L.) extracts as antihyperglycemic and antihyperlipidemic agent in type-2 diabetes-dyslipidemia patients. Int. J. Pharmacol., 6: 456-463.
33. Vijaylakshmi, K., K. Mallikarjun Rao, T.P. Krishna, T.C. Raghuram, P. Eswaran and K. Krishnaswamy, 1999. Dietary factors as determinants of hypertension: A case control study in an urban Indian population. Asia Pacific J. Clin. Nutr., 8: 184-189.
34. Vinik, A.I., T. Erbas, T.S. Park, N. Roger and G.L. Pittenger, 2001. Platelet dysfunction in type 2 diabetes. Diabetes Care, 24: 1476-1485.
35. Vir, S.C. and A.H.G. Love, 1980. Anthropometric measurement in the elderly. Gerontology, 26: 1-8.
36. Warnick, G.R., R.H. Knopp, V. Fitzpatrick and L. Branson, 1990. Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin. Chem., 36: 15-19.
37. Waugh, N., G. Scotland, P. McNamee, M. Gillett and A. Brennan et al., 2007. Screening for type2 diabetes: Literature review and economic modeling. Health Technol. Assess., 11: 1-125.